CD163 and melanoma: We compared their characteristics to the melanoma TAMs, evaluating the expression of CD11b, F4/80, Ly6C, CSF1R, iNOS, CD40, CD86, MHCII, Arg1, CD163 and CD206 expression by flow cytometry.